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Abstract
Increased blood plasma concentrations of the aminothiol homocysteine (Hcy) are
associated with a variety of disease states including those which cause impaired renal
function, many forms of cardiovascular disease, and neurodegenerative diseases such as
Alzheimer's. Therefore, Hcy has the potential to be a significant diagnostic biomarker.
Routine monitoring of Hcy plasma concentration is encumbered by the time and
resources required to quantify Hcy using currently accepted instrumental analysis
methods. As part of the continuing effort to develop a quick, reliable, inexpensive, and
user-friendly test to quantify Hcy at the point of care, we have designed a series of novel
colorimetric and fluorescent chemical probes based on bridged viologen structures. The
absorbance at 540 nm for the para-bridged bis-nitrile viologen probe (pCN) was found to
be proportional to the concentration of Hcy analyte, with LOD = 2.17 µM and LOQ =
6.10 µM where unhealthy Hcy plasma concentrations are > 15 µM. The mechanism of
reactivity between pCN and Hcy encompasses a dynamic set of reactions which involve
pimerization of radical probe species and thioether adduct formation of pCN with Hcy.
Preliminary results with fluorometric analogs of the bridged viologen probes are also
presented.
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1.1 Overview

Chapter 1: Introduction

The biological analyte homocysteine (Hcy) is an important biomarker and
independent predictor for a variety of disease states. The first section of this document
discusses the role of Hcy in the body and the difficulties associated with designing a
chemical probe to easily quantify Hcy in plasma at the point-of-care. This is followed by
a review of established detection techniques as well as novel methodology found in
recent literature. Sections 2.3 and 2.4 conclude the background material with a
discussion of our research group’s previous approach to Hcy detection using viologen
based chemical probes and the theory that led us to investigate the probes used in this
study. Results from our investigation are divided amongst three chapters, the bulk of
which address performance characteristics of colorimetric bridged bis-nitrile viologen
probes (Chapter 3) and examine mechanistic aspects of their unique reactivity (Chapter
4). Chapter 5 briefly summarizes preliminary work with fluorometric bridged biscoumarin viologen probes. A chapter dedicated to concluding remarks precedes sections
detailing experimental methods, notes for future work, and supporting data.
1.2 Relevance of the biological analyte homocysteine
Biological aminothiols maintain intracellular and extracellular redox homeostasis.
Aminothiols such as the amino acid cysteine (Cys) and tripeptide glutathione (GSH) are
considered beneficial and essential to physiological function because they protect cells
from oxidative stress, preventing damage caused by reactive oxygen species (ROS) such
as free radicals and peroxides. GSH can be thought of as a reserve form of Cys since its
1

thiol group comes from a Cys residue. Cys and GSH not only act as antioxidants, they
participate in many metabolic processes as well.1 The thiol group of Cys acts as a
nucleophile in enzymatic reactions and plays an important structural role in protein
folding by forming covalent disulfide bridges between Cys residues.2
In recent years there has been increased interest in a related aminothiol,
homocysteine (Hcy), as a biological analyte and a potential risk factor for a variety of
disease states.3 It is a homologue of Cys and an intermediate in the biosynthesis of Cys
from methionine.4 Hcy and Cys differ only by a single methylene group (Figure 1);
however, Hcy is rarely incorporated in proteins by translation, only occasionally
replacing methionine residues.5

Figure 1. Structures of biological aminothiols homocysteine (Hcy), cysteine (Cys), and
glutathione (GSH).
Normal plasma concentrations of Hcy in healthy adults can range from 5 – 15
µM. An elevated level of Hcy in plasma (>15 µM) is a condition known as
hyperhomocysteinemia and is considered detrimental to physiology.6-10
Hyperhomocysteinemia can be caused by environmental factors, disease, poor nutrition,
or genetic disorders. For example, certain endocrine diseases such as hypothyroidism or
diabetes mellitus can cause elevated levels of Hcy by modulating Hcy metabolism. 11-13

2

Kidney disease can lead to poor renal clearance of Hcy from circulation. 14 Chronic
consumption of alcohol has also been observed to increase levels of Hcy.15-16
Homocytinuria is a genetic disorder which leads to the abnormal accumulation of
Hcy in blood and urine. Homocytinuria type I is a recessively inherited autosomal defect
in the transulfuration pathway which catabolizes excess Hcy into Cys. 4 Types II and III
are recessively inherited defects in the remethylation pathway which convert the thiol
group of Hcy into a thioether to form methionine (Figure 2). Methylenetetrahydrofolate
reductase (MTHFR) synthesizes 5-methyltetrahydrofolate, the major carbon donor for
remethylation. Reduced function polymorphisms in MTHFR occur in about 10% of the
world’s population.17-19

Figure 2. Homocysteine metabolism.20-21
3

Excess Hcy disrupts the structure and function of proteins by degrading cysteine
disulfide bridges (S-homocysteinylation) and forming an amide bond with the ε-amine of
lysine residues (homocystamides).22-24 This affects extracellular matrix components such
as collagen, elastin, and proteoglycans causing damage to endothelial tissue.25-27 Hcy is
also implicated in the peroxidation of low density lipids. 28 Both, damaged endothelia
tissue and oxidized low density lipids, activate platelets and increase platelet aggregation
which leads to thrombogenicity.29
Since Hcy is toxic to endothelial tissue and can induce clotting, Hcy could be a
causal risk factor for cardiovascular disease. Many clinical studies have demonstrated
significantly increased concentrations of Hcy at each stage of ischemic heart disease,
from the onset of atherosclerosis to eventual myocardial infarction or stroke.30-34
Monitoring Hcy levels in blood plasma can help predict and possibly prevent these health
issues.35
Hcy has also been proposed as a novel early warning biomarker for
neurodegenerative diseases.36 Accumulation of Hcy in circulation corresponds to an
increased concentration of Hcy in the interstitial fluid of the central nervous system. This
is associated with decreased plasticity in hippocampal neuronal cells, 37 reduced cerebral
white matter volume, larger ventricles, and ultimately lower cognitive functioning. 38
Abnormally high levels of Hcy have been found in patients who suffer from various
forms of dementia such as schizophrenia and Alzheimer’s disease. 39-41 Furthermore,
hyperhomocysteinemia is known to cause neural tube defects in embryos and other
complications during pregnancy.42
4

Although high plasma concentrations of Hcy have been firmly established to
independently predict cardiovascular disease and modes of Hcy toxicity have been
demonstrated in several ex vivo studies, a controversy has developed over the causal
relationship of between Hcy and disease. Researchers Smulders and Blom reviewed the
literature and concluded the reluctance to formally implicate Hcy as a true ‘risk factor’
was primarily based on results from two types of clinical experiments: intervention
studies and Mendelian genetic studies.43 Intervention studies that treated patients who
initially presented with high levels of Hcy did not result in a lower instance of
cardiovascular disease. Problems with Hcy metabolism due to reduced function
phenotypes or environmental factors such as poor diet can be corrected by treatment with
vitamin B supplements. Since the buildup and degradation of atherosclerotic plaques are
extremely slow processes, the duration of intervention studies may have been too short to
observe a statistical improvement. Excessive vitamin B intake might have been
counterproductive, causing inflammation and spreading of existing atherosclerotic
lesions. Mendelian randomized genetic studies of MTHFR polymorphisms have reported
conflicting results. Population variance in Hcy concentration does not arise exclusively
from a single polymorphism. Without controlling the influence of confounding factors
and other risk factors the results of these genetic studies are inconclusive. Regardless of
culpability, measurements of plasma Hcy concentration remain valid for the prediction
and diagnosis of many diseases.

5

Chapter 2: Prior art
2.1 Traditional methods for Hcy quantification
As an important biological analyte, the direct detection of Hcy in plasma is hindered
by the presence of structurally related matrix components such as Cys and GSH. The
interference can be significant since normal plasma concentrations of reduced free Cys
and GHS are approximately 200 - 300 µM and 3 - 7 µM respectively, compared to a
normal Hcy plasma concentration of 5 – 15 µM.8-9, 44-46 Additionally, Hcy is largely
invisible to most spectroscopic detectors because it is not a strong chromophore in either
the UV or visible regions.47 Therefore, quantification techniques typically employ
chromatographic separations followed by electrochemical detection, derivatization for
spectrophotometric detection, or mass spectrometry.48-49
While these techniques generally produce excellent sensitivity and selectivity, they
are not without disadvantages: Peak overlap from coelution of cysteinyl-glycine,
normally present at 35.0 ± 5.8 µM in plasma,44-45 and insufficient column regeneration
contribute to poor specificity with many chromatographic protocols.50 The electrodes
used in postcolumn electrochemical detection tend to leach redox mediators, deteriorating
the measurement cell over time and leading to poor reproducibility.48 Post- or precolumn
derivatization introduces additional sample processing steps and additional reagents such
as the chromophore and internal standard. Furthermore, the instrumentation used for
these techniques is prohibitively expensive for point of care testing and requires skilled
personnel to operate. Sample processing is often labor intensive and time consuming.
Such low throughput protocols are unsuitable for routine diagnostic applications. 51
6

Enzymatic and immunoassays are also available for Hcy determination. Although
these assays are less labor intensive, they utilize fragile biomolecules which tend to be
expensive and problematic to store.49 High concentrations of hemoglobin from
hemolysis, bilirubin from icterus, or triglycerides from lipemia are known interferences. 52
Inter- and intralaboratory variation has also been reported with these assays.51-55 Ideally,
inaccuracy from systematic error inherent in a particular assay should be < 10% and
imprecision for replicate measurements of the sample should be < 5%.51 However, a
2008 study comparing six different commercially available biomolecule based assays
confirmed inaccuracies which ranged from -29.3% to 7.2% and imprecisions from 1.7 to
9.4%. Five of the six assays determined Hcy concentrations in standardized samples that
were outside of the NIST-certified range.52
2.2 Selective Hcy detection without chromatography or biomolecule reagents
There are many chemical probes available for the direct detection of total thiols in
biological fluids. Since thiol groups are nucleophilic, the mechanism often involves
substitution or addition to a chromophore. Some probes have been reported to react
selectively with Cys in the presence of other aminothiols. Cys selectivity is primarily
attributed to its smaller size for accessing hindered reactive sites, the lower pKa of its
thiol group (pKa SH: Hcy22 = 10.0, Cys22, 56 = 8.33, GSH56-57 = 9.12), or its ability to
form kinetically favored five membered heterocycles.58-63 However, very few probes
have been shown to detect Hcy selectively in the presence of Cys because their chemical
structures are so similar.
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Chen et al. reported an iridium based phosphorescent probe which responded
selectively for Hcy when compared with analytes Cys, GSH, and other amino acids
(Figure 3).64 While both, Hcy and Cys, formed adducts with the probe, the proposed
mechanism for selectivity implicated a photoinduced electron-transfer process which
caused emission quenching for the Cys adduct. However, the reaction was performed
with a high ratio of organic solvent (9:1 v/v DMSO:HEPES buffer) which is generally
not useful for biological samples. The minor response observed for Cys and use of 200
equivalents of Hcy to probe would also have a significant impact on accuracy and
sensitivity when realistic biological concentrations of the analytes are measured.

Figure 3. Iridium (III) based chemical probe.
Recently, resonance light scattering (RLS) from metal nanoparticles has been
employed to determine Hcy in biological fluids (Figure 4). Xiao et al. reported the
kinetics of Cys induced aggregation of fluorosurfactant-capped gold nanoparticles to be
rapid at pH 12 while nearly identical for Hcy and Cys at pH 6.5.65 Thus, by changing the
pH and measuring RLS, Hcy and Cys could be quantified. The technique was
demonstrated in urine with good recoveries. However, the ionic strength of the samples
can have a dramatic effect on selectivity and gold tends to be an expensive reagent. Sun
et al. reported an enhanced RLS signal from Hcy induced assembly of polyaziridine
silver nanoclusters.66 Ultrafiltration was necessary to eliminate RLS interferences from
8

serum samples. Optimal reaction conditions also required heating to 70 ᵒC and the
unstable silver nanoclusters cannot be stored longer than two weeks.
A

B

Figure 4. (A) Aggregation of fluorosurfactant-capped gold nanoparticles.67 (B)
Assembly of polyaziridine silver nanoclusters.66
Yu et al. designed a nanoparticle probe using mesoporous silica with polyethylene
glycol (PEG) covalently bound to the outer surface.68 The silica pores were loaded with
an anthracene nitroolefin fluorophore (6). Nirtoolefins undergo Michael addition with
thiols unselecively, however the PEG acted as a selective barrier which prevented other
aminothiols from entering the nanoparticle to react with the fluorophore (Figure 5). The
probe was demonstrated to be Hcy selective by comparing the fluorescence increase of
Hcy, Cys, and GSH at 50 µM each. Some fluorescence increase was observed with Cys
and GSH. Since biological concentrations of Cys are ~20 time higher than Hcy, the
response due to Cys would become significant. Furthermore, the complexity of the probe
introduces multiple variables such as particle size and fluorophore loading which would
need to be controlled in order to achieve good reproducibility.

9

Figure 5. Mesoporous silica nanoparticle (MSN) loaded with fluorophore 6 and coated
with PEG.68
Gholami-Orimi et al. have reported the voltammetric determination of Hcy in
directly in urine and serum using carbon nanotube paste electrodes with chlorpromazine
as a mediator (Figure 6).69 However, the endogenous Hcy concentrations in the
biological fluids were below the detection limit. The serum samples required 50 µM of
additional Hcy to be added before it could be detected. The method relied on square
wave voltammetry, which detects the oxidation or reduction of a species. Though the
authors studied interferences from some common sugars and amino acids, they did not
address possible interference from Cys, GSH, or foreign reducing agents commonly used
to free Hcy bound by disulfide linkage.

Figure 6. Chlorpromazine mediator for voltammetric detection of Hcy with carbon
nanotube paste electrodes.
10

2.3 Selective detection of Hcy by the α-amino carbon-centered radical
Thiol groups are easily oxidized to form thiyl radicals. In biological systems,
thiyl radicals are generated a variety of ways (Figure 7):70 Thiyls are most commonly
formed by radical propagation such as in the hydrogen atom transfer (HAT) from the
thiol group of GSH to the C4′-centered sugar radical of damaged DNA during the “repair
reaction.” Thiyls can also be formed during oxidative stress by ROS such as H2O2, by
homolytic cleavage of disulfides to produce two thiyl species, or though enzymatic
oxidation of thiols by some peroxidases. In turn, the thiyl radicals of aminothiols like
Hcy, Cys, and GSH can undergo intramolecular HAT reactions to generate an α-amino
carbon-centered radical.71

Figure 7. Some common routs to thiyl radical formation: (1) pH dependent formation of
thiolate and subsequent oxidation to thiyl. (2) Oxidation to symmetric or mixed
disulfides followed by (3) Homolytic cleavage of disulfide. (4) Reaction with generic
radical species, •X, or other ROS. (5) Formation of disulfide radical anion.
The rate of interconversion from the thiyl radical to the α-amino carbon-centered
radical by intramolecular HAT is influenced by the geometry of the transition state. Hcy
forms a kinetically favored 5-membered ring transition state while Cys and GSH form 4
and 9 membered rings in their respective transition states (Figure 8). The carbon radical
11

is captodatively stabilized by the geminal amine and carboxylate. 71 With a weakly
acidic pKa of ~8-10, thiols and their conjugate thiolate anions are relatively stable
species. Therefore, the electron deficient thiyl radical is an oxidizing species with
standard potential E°red = 1.35 ± 0.04 V.72 However, the α-amino carbon-centered
radical is known to be a reducing species (E°red ≈ -0.55 ± 0.10 V)73 due to iminium ion
stabilization of the carbocation resulting from the loss of an additional electron from the
carbon-centered radical.74

Figure 8. Formation of α-amino carbon centered radical from thiyl radical by
intramolecular HAT. Five membered ring transition state of Hcy (1a) is favored as
compared to the four membered ring of Cys (2a) or nine membered ring of GSH (3a).
In addition to transition state geometry, intramolecular HAT for aminothiols is
also influenced by pH. At high pH the amine group is predominately neutral and can
donate electron density to the α-carbon. This causes the α-C-H bond to be substantially
weaker than expected for a tertiary carbon and several kJ/mol lower than the S-H bond.75
Since the equilibrium of amine to ammonium cation is pH dependent, the activation
energy barrier for HAT and subsequent concentration of α-amino carbon centered
radicals is also pH dependent. Thus the effective reduction potential of the aminothiols
varies with pH.73
In 1994, Zhao et al. utilized the moderate electron acceptor methyl viologen
(MV2+) (E°red = -0.448 V) as a probe to study the carbon-centered radicals of Hcy, Cys,
12

and GSH.71 Originally colorless, MV2+ (9) turns blue from increased absorptions at 398
and 605 nm produced by the reduced radical cation species, MV•+ (9a) (Figure 9). The
authors observed reduction of MV2+ to colored MV•+ by each of the aminothiols without
apparent selectivity for Hcy. Under the experimental conditions, pH 10.5, thiolate and
thiyl species are abundant and readily form reducing disulfide radical anions (E°red ≈ -1.7
V) irrespective of aminothiol identity (Figure 7, Equ. 5).73 At this pH, facile
intramolecular HAT and the presence of disulfide radical anions account for the nonselective reduction of MV2+.

Figure 9. Mechanism for MV2+ probe: Oxidative thiyl radical of homocysteine (1a)
undergoes HAT to form the reducing α-amino carbon-centered radical (1b). MV2+ (9) is
then reduced by 1b to produce blue MV•+ (9a) and the α-amino carbocation (1c) which is
stabilized by iminium formation (1d).
In 2004, the Strongin research group pioneered the direct detection of Hcy in
plasma using chemical probes by showing a selective color change can be achieved with
the MV2+ probe at neutral pH under refluxing conditions (Figure 10).76 Selectivity relied
on the diminished presence of disulfide radical anions and attenuated ability for Cys and
GSH to undergo intramolecular HAT at lower pH. A follow-up study was done in which
a series of bis-substituted viologen probes were refluxed in the presence of Hcy or Cys.73
As expected, color formation was observed to be pH dependent, corresponding to the
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reduction potential of the probe. In general, probes with a less negative reduction
potential were able to be reduced by the aminothiols at lower pH. Additionally, Hcy was
able to reduce the probes at a lower pH than Cys due to the kinetically favored formation
of the α-amino carbon-centered radical (Figure 11).
A

3.79 µM

6.13 µM

13.4 µM

38.7 µM

B
Figure 10. (A) Selective color change, MV2+  MV•+. Human plasma spiked with 4.0
mM of each aminothiol, 8.0 mM MV2+, buffered to pH 7.5 with 0.5 mM Tris, and
refluxed for 5 min. Inset shows samples before heating.61 (B) Proportional probe
response to endogenous Hcy concentrations in human serum calibration standards in the
presence of disulfide reducing agent, tris(2-carboxyethyl)phosphine (TCEP).62

Figure 11. Minimum pH at which Hcy or Cys (17 mM) produced colorimetric response
with various symmetric viologen probes (4.0 mM).73
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2.4 Novel viologen based probes
While the selective detection of Hcy directly in human plasma was an impressive
achievement by our research group, the use of heat to promote the reaction was not ideal
for simple, high-throughput testing or an at-home testing kit. During our investigation of
symmetric viologen probes, the probes with less negative reduction potentials were
observed to have a persistence of color when removed from the heat, a more intense color
change, and a faster onset of color when the pH of the solution was increased beyond the
colorimetric endpoint.73 Therefore, it was thought that tuning the redox properties of the
viologen probe would allow for the selective detection of Hcy without the need for
reflux.
At high concentrations, the radical cation species of viologens have been shown
to associate by cofacial π-stacking to form intermolecular pimers.77 These pimers are
stabilized by spin paring of the free radicals to a diamagnetic state.78 In addition to
radical stabilization, cofacial proximity of a radical cation species to a fully oxidized
dictation species causes the dictation to be more easily reduced. 79 By tethering two
viologen molecules together with a xylene linker, the proximity of the viologens subunits
can be adjusted via ortho, meta, or para isomers of the linker. The termini of the bridged
viologens could then be further functionalized, providing a tuned reduction potential
amenable to room temperature reduction and the formation of stable radical species.
The use of a bridged viologen probe was also seen as an opportunity to explore
possible supramolecular sensing mechanisms. Since the rotatable bonds of the bridge
allows for a range of open and closed conformations, there is likely to be conformational
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rearrangement upon reduction.79 Binding of an analyte may also cause a conformational
change whereby selectivity for a particular analyte would be delimited according to the
size of the closed conformation cavity. These conformational changes could be
monitored by functionalizing the termini of the probe with fluorophores, since short
range interactions of the fluorophore moieties would result in enhanced florescence or
quenching.
Initial screening of bis- benzyl, allyl, propargyl, acetal, carboxylate, and nitrile
analogs of the bridged viologen probe revealed the nitrile analog to be the most
promising candidate for the selective room temperature detection of Hcy near
physiological pH.80 The work herein details the characterization of ortho, meta, and para
isomers of the bis-nitrile bridged viologen probe, addresses issues with optimization of
this probe for use with biological samples, and proposes a mechanism for the observed
reactivity. Additionally, coumarin was chosen as a convenient fluorophore for
preliminary studies of supramolecular interactions (Figure 12).
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Figure 12. Structures of bridged viologen based probes.
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Chapter 3: Results and discussion
3.1 Detection of Hcy with the para-bridged bis-CN viologen probe
Selective detection of Hcy at room temperature was achieved using para-bridged
bis-CN viologen (pCN, 12). At pH 8, the probe developed a red color in solution with
Hcy while solutions containing Cys or GSH remained a similar color to the blank. In
Figure 13, the concentrations used for the Cys and GSH controls reflect their normal
biological concentration in human plasma, while 15 µM of Hcy was used to represent
mild homocysteinemia.
A

B
Figure 13. Colorimetric selectivity for Hcy in 80.0 mM phosphate buffer pH 8.0 with
2.00 mM pCN probe. (A) Photo after 20 min at room temperature. From left: blank,
15.0 μM Hcy, 250 μM Cys, 6.00 μM GSH, all thiols combined. (B) Measured λabs = 540
nm increased over time.
There were two absorbance peaks observed in the visible region, λ abs = 413 and
540 nm (for behavior at 413 nm see Section 3.3). Both of the peaks increased with time;
however, the peak at 540 nm increased at a faster rate in the presence of Hcy (Figure 13B). After several hours, the absorbance increase due to Hcy plateaus and converges with
the level of absorbance produced by Cys or GSH, making solutions of the aminothiols
indistinguishable. Interestingly, probe response at 540 nm in the presence of Cys was
slightly lower than the response of the blank; though the rate of increase was similar.
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The presence of Cys may be responsible for the attenuated response observed for Hcy
when all of the aminothiols are combined.
Plasma proteins were also found to interfere with the probe response, causing the
probe to become intensely colored. Deproteinization was necessary to distinguish
samples spiked with Hcy from blank samples. After deproteinization the probe behaved
similarly to the non-plasma buffer controls (Figure 14). There was, however, a slight
decrease in overall absorbance. This was attributed primarily to the high salt content of
plasma (see Section 3.3).

Figure 14. Selective color change in presence of 25% v/v deproteinized bovine plasma.
Photo after 20 min at room temperature in 80.0 mM phosphate buffer pH 8.0 with 2.00
mM pCN probe. Aminothiols were spiked according to: blank, 15.0 μM Hcy, 250 μM
Cys, 6.00 μM GSH, all thiols combined.
Calibration curves for Hcy were constructed with Hcy spiked to deproteinized
plasma. Accounting for the plasma dilution, the curve in Figure 15-A was spiked with
normal biological concentrations of Cys and GSH. This curve appeared linear, though
the deviation of the replicates was not ideal. Since the blank was only measured once,
the limit of detection (LOD) was calculated by regression statistics according to the
formula LOD = 3 x [standard error of y values] / [slope]. The limit of quantification
(LOQ) was calculated according to LOQ = 10 x [standard error of y values] / [slope]. For
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the diluted sample solutions: LOD = 3.40 µM and LOQ = 11.3 µM. These values
correspond to LOD = 13.6 µM and LOQ = 45.3 µM in the plasma after accounting for
the dilution. When higher concentrations of deproteinized plasma were used, the
absorbance measurements were not significantly different. However, a modest dilution is
anticipated from sample processing steps needed to remove erythrocytes and proteins if
this probe is to be used for a point-of-care test kit (see Chapter 8).
The calibration curve in Figure 15-B was constructed using a slightly higher pH
buffer, pH 8.3 instead of pH 8.0. At higher pH, the sensitivity of the probe increases;
however, the increase in reactivity also leads to an increase in response to reductants
other than Hcy. Although the response from Cys and GSH at pH 8.3 is negligible, the
data for this calibration curve was collected without spiking Cys or GSH in an effort to
identify the variable most responsible for replicate deviations. The precision of the
replicates improved though the data points appear to be slightly non-linear (concave
down). Since replicates of the blank were performed, LOD and LOQ were calculated by
3 x [standard deviation of the blank] and 10 x [standard deviation of the blank]. It should
be noted that the blank had the largest deviation in the data set, thus the limits may be
artificially inflated by a potential outlier. For the diluted sample solutions: LOD = 2.17
µM and LOQ = 6.10 µM. These values correspond to LOD = 8.67 µM and LOQ = 24.4
µM in the plasma after accounting for the dilution. Even though the slope of the curve
was increased by increasing the pH, the sensitivity was not improved enough for the
LOQ to fall within the range of the curve (for an alternative curve based on initial rates
see Appendix A, Figure 47).
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B

Figure 15. Calibration curves for pCN probe. All samples contained 25% v/v
deproteinized bovine plasma, 2.00 mM pCN probe, and 80.0 mM phosphate buffer.
Absorbances measured at 540 nm after 30 min. (for λabs and time point selection see
Appendix A, Figure 45 and Figure 46) (A) pH 8.0 with 62.5 μM Cys and 1.50 μM GSH
spiked to each sample. LOD = 3.40 µM and LOQ = 11.3 µM. (B) pH 8.3 without Cys
and GSH. LOD = 2.17 µM and LOQ = 6.10 µM.
3.2 Ortho and meta isomers of the bridged bis-nitrile viologen
The ortho-bridged bis-nitrile viologen (oCN) and meta-bridged bis-nitrile
viologen (mCN) were also found to respond selectively to Hcy under certain conditions
(Figure 16). The local maximum λabs for oCN was determined to be 550 nm, while mCN
and pCN had maximums at 540 nm. The 10 nm redshift and broader peak gives the
reduced oCN probe a purple appearance that is unique among the positional isomers.
The purple color was attributed to skewed intramolecular pimerization of the viologen
moieties. Pimerization or ‘π-dimerization’ is the cofacial stacking and interaction of πsystems. When two viologen radical cations pimerize (P2), the spins of the SOMO
electrons pair to form a diamagnetic closed shell without actually forming a bond. This
localizes the stabilizes the radicals, resulting in a larger ground state to excited state
energy gap (ΔE) and λabs blueshift compared to the monomeric radical. The magnitude of
ΔE is partially dependent the extent of π-orbital overlap allowed with bridged or
sterically hindered pimer subunits. Increasing the distance between viologen moieties or
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skewing orbital alignment by reducing the degrees of freedom gives a λabs redshift
relative to the ideal P2 geometry. When the π-stacking occurs between an unreduced
dication and a radical cation viologen (P2•+), the electrostatic interaction causes
delocalization of the free electron and a redshift results. 77, 81-83
A

B

C

D

Figure 16. All panels show 200 µM of each aminothiol at pH 7.0 (A) 4.00 mM oCN,
80.0 mM phosphate buffer, 200 mM NaCl. (B) 8.00 mM mCN, 80.0 mM HEPES buffer.
(C) oCN absorbance spectrum at conditions from panel A measured at 22 min. (D) mCN
absorbance spectrum at conditions from panel B measured at 30 min.
Ortho xylene bridged viologens form mostly intramolecular pimers whereas meta
and para isomers tend to form intermolecular pimers.77 Additionally, pimerization
occurs preferentially with oCN because the tethered viologen moieties are already
positioned in close proximity, minimizing translational and rotational components of the
activation energy barrier. The acceptor/donor interaction of the oCN pimer is a charge
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transfer complex which stabilizes the radical cation. Therefore, the pimer is formed more
easily than an unassociated radical cation.82 This means the first reduction potential of
tetracationic oCN is less negative than the mCN and pCN isomers. For a given pH, oCN
was observed to be more reactive than mCN and pCN. Figure 16-CD shows similar
absorbance intensities for oCN and mCN; however, the spectrum for oCN corresponds to
an earlier time point and half the probe concentration. Although oCN possessed
increased reactivity and both isomers appeared to have an intense, selective response to
Hcy, the optimization of these probes did not reveal reaction conditions at which a useful
LOD could be obtained.
3.3 Effects of reaction parameters
There was a decrease in reactivity of the bridged bis-nitrile viologen probes as
ionic strength was increased by the addition of NaCl (Figure 17-A). Similarly, Kertesz et
al. observed a decrease in Cys thiyl radical when ionic strength was increased. 84 The
authors rationalized this observation by invoking counter ion clusters which surround
charged molecules in solution, thereby retarding their interaction and ability to generate
radicals. This diffusion limiting explanation is only partially satisfying for the bridged
viologens since the response of the probe in solution without aminothiols (designated as
‘blank’) also decreased. Other considerations may include increased radical quenching
and geminal recombination with the increased dielectric nature of the solution and an
increase in the dissociation constant of viologen pimers by counter ion stabilization of the
monomers.85 Interestingly, the probe response due to GSH was more affected by ionic
strength than the other aminothiols. It appeared that controlling the ionic strength would
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be useful to block interference from GSH and promote selectivity towards Hcy; however,
the response due to GSH at biological concentrations (3 - 7 µM in plasma) was minimal
with the pCN probe under optimal conditions.

A

B

Figure 17. Effect of ionic strength and buffer identity. (A) 4.00 mM oCN, 200 µM of
each aminothiol, 80.0 mM phosphate buffer pH 7.0, λabs = 550 nm, after 30 min. (B) 8.00
mM mCN, 200 µM of each aminothiol, 80.0 mM buffer pH 7.0, λabs = 540 nm, after 30
min.
The bridged bis-nitrile viologen probes also behaved differently in different
buffers. Three types of buffers were examined: anionic phosphate, zwitterionic HEPES,
and cationic Tris. For mCN, it was found that HEPES buffer provided the best selectivity
towards Hcy (Figure 17-B), while oCN and pCN produced better results in phosphate
buffer. For all three isomers, a dampening of probe response was observed with
increasing concentration of phosphate buffer, presumably due to the accompanied
increase in ionic strength. Higher concentrations of Tris buffer had the opposite effect,
causing an increase in the probe response. However, consistently poor selectivity for
Hcy was observed when Tris was used.
Surfactants were also investigated as a way to remove protein interference by
denaturing them or by sequestering the probe from interferences. The observations
attributed to the formal charge of the buffers, did not hold with surfactants. The anionic
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surfactant, SDS, caused the probe to turn purple and precipitate from solution. Neutral
surfactant, Tween 80, caused an increase in probe response and loss of selectivity.
Cationic surfactant, CTAB, did not appear to affect the probe up to the highest
concentration tested, 10 mM. The addition of CTAB to plasma samples did not block
interferences.
One possible explanation for the variability observed with these additives is the
extent to which they solvate the probe along its reaction coordinates. As a tetra-cationic
species, the unreduced probe is soluble in an aqueous medium. Upon reduction, the
charge decreases and the probe becomes increasingly less soluble. Fully reduced, neutral
bridged viologens precipitate completely from aqueous solutions. 77 A reduction in
solubility due to the loss of charge is enthalpically and entropically disfavored, causing
an increase in the energy of the activation complex. 86 By increasing the organic character
of the medium, the activation complex is stabilized and reduction of the probe occurs
more readily. This difference in solvation energy of the activation complex has been
attributed to the increasingly less negative reduction potential observed for MV 2+ when
the dielectric constant of the solvent was decreased by adding ethanol. 87
The effect of adding water miscible organic solvents was investigated using
acetone, methanol, ethanol, isopropanol (IPA), dimethyl sulfoxide, dimethylformamide,
tetrahydrofuran, dioxane, and acetonitrile. As expected, the probe response increased
proportionally to the ratio of organic solvent used, with only subtle differences in
intensity and selectivity. In strictly aqueous solutions buffered at pH ≤ 6.0, none of the
bridged bis-nitrile viologen probes produced notable increases of absorbance in the
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visible region. However, with the addition of organic solvent, the probes would respond
below pH 6. At low pH and with added organic solvent, Cys became a prominent
interference. There was no discernible difference between protic and non-protic solvents;
though probe reactivity was observed to increased according to the trend methanol >
ethanol > IPA.
A

B
Figure 18. Samples with organic solvent. (A) Selective color change for Hcy after 20
min in 80.0 mM phosphate buffer pH 8.0 with 25% v/v deproteinized plasma, 15% v/v
IPA, 0.500 mM pCN probe. From left: blank, 15.0 μM Hcy, 250 μM Cys, 6.00 μM GSH,
all thiols combined. (B) λabs = 540 nm in 80.0 mM phosphate buffer pH 8.0 with 15%
IPA and 0.500 mM pCN probe.
When high concentrations of organic solvent were used the samples would
become completely opaque with color, obscuring any potential selectivity. Visual
selectivity for Hcy in 15% IPA became discernible again when the pCN probe
concentration was decreased by a factor of four (Figure 18-A). Although the colors of
the vials appear similar to those in Figure 14, there were some distinct differences in the
absorbance spectra. The sample designated by ‘all’ contained a mixture of Hcy, Cys, and
GSH at concentrations respective of those used for the individual analyte samples.
According to measurements of the diagnostic peak at 30 min, the species responsible for
absorbtion of yellow-green light at λabs = 540 nm and the appearance of red colored
solutions was present at the same concentration in the sample with 6 µM GSH as
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compared to the sample that contained ‘all’ the aminothiols together (Figure 18-B). This
discrepancy between the observed color and measured absorbance has to do with a
decrease in the rate of absorbance increase at 413 nm relative to 540 nm (Figure 19). An
equilibrium shift away from species responsible for the peak at 413 nm was attributed, in
part, to increased pKa values associated with the use of less polar solvents (Ka of probes
discussed in Section 4.2).88 The peak at 413 nm was absorbing violet light and
contributed to the appearance of yellow colored solutions. The GSH samples in IPA
appeared visibly yellow after 30 min because the peak at 413 nm dominated, while this
peak was less prominent for the ‘all’ sample. Increased interference at λabs = 540 nm
from Cys and GSH in the presence of organic solvent was also observed (Figure 20).
This is most likely due to the decreased probe to analyte ratio and increased radical
disproportionation of the analytes prior to interaction with the probe.
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Figure 19. Effect of adding organic solvent. (A) Spectrum of 2.00 mM pCN in 80.0 mM
phosphate buffer pH 8.0 with 15.0 µM Hcy. Time frame: 0 - 30 min with a scan every 2
min. (B) λabs = 413 nm corresponding conditions from panel A. (C) Spectrum of 0.500
mM pCN in 80.0 mM phosphate buffer pH 8.0 with 15.0 µM Hcy and 15% v/v IPA.
Time frame: 0 - 30 min with a scan every 2 min. (D) λabs = 413 nm corresponding to
conditions from panel C.
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Figure 20. Effect of Cys and GSH concentrations, with and without organic solvent. All
panels: λabs = 540 nm at 30 min in 80.0 mM phosphate buffer pH 8.0 with 15 µM Hcy
constant where indicated. (A) 2.00 mM pCN probe with Cys concentration varied. (B)
2.00 mM pCN probe with GSH concentration varied. (C) 0.500 mM pCN probe in 15%
IPA with Cys concentration varied. (D) 0.500 mM pCN probe in 15% IPA with GSH
concentration varied.
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Chapter 4: Mechanism of the bridged bis-nitrile viologens
4.1 Non-bridged control experiment
To assess the way bridging the viologens effected reactivity, a non-bridged
asymmetric viologen was synthesized with methylene nitrile and benzyl substituents
(Figure 21). The non-bridged, benzyl-nitrile-viologen (BNV, 16), showed similar
reactivity as pCN in regards to producing absorbance peaks at 413 nm and 540 nm. BNV
also produced the familiar red color in the presence of Hcy under the same conditions as
pCN, though twice the concentration of BNV was necessary to produce comparable color
intensity.

Figure 21. Structure of bridged pCN compared with non-bridged BNV.

A

B

Figure 22. Comparison of pCN and BNV reactivity over 12 hrs. Measurements made
every 15 min. Samples in 80.0 mM phosphate buffer pH 8.0 with 15% v/v IPA. Probe
concentrations: 1.00 mM pCN or 2.00 mM BNV. 15.0 µM Hcy and bk = blank where
indicated. (A) λabs = 413 nm. (B) λabs = 540 nm.
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When absorbances were measured over 12 hours, BNV revealed a slightly
different reaction profile than pCN (Figure 22). The rate of absorbance increase at 413
nm was slower for BNV compared to a stoichiometric equivalent of pCN. BNV also had
a slower rate of absorbance increase at 540 nm when no Hcy was present while samples
with Hcy had nearly identical absorbance rates at 540 nm. Interestingly, both probes
show a decline in absorbance at 540 nm after reaching a maximum. At 413 nm, the
absorbance reaches a maximum, but does not decline. Samples left on the lab bench
longer than 36 hrs appeared uniformly yellow/brown from the diminished absorbance at
540 nm and persistence of the absorbance at 413 nm.
Another difference between pCN and BNV was the measured pKa values. When
a solution of BNV was titrated with dilute NaOH, a buffering region was observed which
corresponded to a pKa of 8.38. When pCN was titrated there were two regions where the
pH remained constant with the addition of base, pKa1 = 6.83 and pKa2 = 7.92 (see
Appendix A, Figure 49 and Figure 50). Increasing cofacial interaction between viologen
moieties by holding them in close proximity to each other with a xylene bridge is known
to enhance pimerization.89 Tethering increases the local positive charge density and
facilitates charge distribution through pimerization. Therefore, the electron withdrawing
property of the pyridine rings was increased for the bridged probe, substantially
weakening the methylene C-H bond relative to the non-bridged probe.
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4.2 Acidic protons of the bridged probes
The pH dependent reactivity and selectivity of non-bridged N-methylene
functionalized viologens was originally attributed to the reduction potential of the probe
and pH dependent formation of reductive analyte radical species. 73 However, the
reactivity of these types of probes may be due, in part, to labile hydrogens vicinal to
electron withdrawing groups. Figure 23 shows gradual deuterium exchange of hydrogens
at peak ‘b’ when samples of the pCN probe were left in D2O. This indicated the presence
of acidic hydrogens on the probe and a potential site of reactivity. Radicals may be
generated by oxidation, reduction, or homolytic cleavage. If the probe undergoes a
typical acid/base proton transfer, then a conjugated non-radical species would result.
This species may be responsible for the absorbance at 413 nm which makes the solution
appear yellow. If the labile hydrogen is removed by intermolecular HAT, a radical
species is produced which absorbs 540 nm and causes the solutions to appear red (Figure
24).83
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Figure 23. 1HNMR of pCN showing deuterium exchange in D2O. (A) Methylene
hydrogens immediately after preparing NMR sample. (B) Methylene hydrogens after 1
hr. (C) Structure of pCN showing peak assignments.

Figure 24. Modes of cleavage for labile hydrogen. Here ‘•X’ is any radical species.
In the case of MV2+ (9), solutions were heated to reflux in order to transfer and
sustain a radical on the viologen probe. Oxygen is known to compete with MV2+ in
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radical reactions and quench MV•+, so it was thought that reflux was required to drive
dissolved oxygen from solution.90-91 For the bridged bis-nitrile viologen radical species,
such as 12a, there is increased stabilization of the radical by delocalization in the
extended conjugation of the π-system. This resonance stabilization contributes to
reactivity at room temperature and persistence of the radical species. Furthermore, when
the sample solutions were enriched with oxygen, pCN reacted at a faster rate with Hcy.
Conversely, when argon was aspirated through the solutions to purge oxygen, pCN
reacted at a slower rate with Hcy (see Appendix A, Figure 51). This indicated oxygen
was acting as a reactant or a radical mediator rather than an inhibitor, suggesting a more
complex mechanism than direct reduction of the probe by the α-amino carbon centered
radical.
To assess the involvement of the α-amino carbon centered radical, other thiol
reducing agents were tested as controls (Figure 25). 2-Mercaptoethanol (BME, 17) and
3-Mercaptopropionic acid (MPA, 18) were chosen because their pKa values for the thiol
group are similar to Hcy (pKa SH: Hcy22 = 10.0, BME92 = 9.7, MPA92 = 10.3) and they
are not able to produce a captodatively stabilized carbon centered radical. The strong
probe response produced by Hcy in comparison to BME and MPA implicated the αamino carbon centered radical of Hcy as an augmenting factor. However, the response
observed with BME and MPA in comparison to the blank suggested radical species
generated by the thiol group, such as thiyl radicals and radical disulfide anions, were
propagated to produce the red colored radical species of the probe.
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Figure 25. Non-amino thiol controls. Structures from left: Hcy pKa = 10.0; 2Mercaptoethanol (BME) pKa = 9.7; 3-Mercaptopropionic acid (MPA) pKa = 10.3.
Photo: 2.00 mM pCN probe in 80.0 mM phosphate buffer pH 8.0 with 50.0 µM of the
indicated thiol after 20 min.
4.3 Electron paramagnetic resonance spectroscopy
Electron paramagnetic resonance (EPR) spectroscopy was used to confirm radical
propagation from Hcy to the pCN probe. The magnetic moment of a free electron is
called the spin g-factor (g). If paramagnetic electrons are present, the value of g
calculated from EPR spectral measurements should be near the accepted magnetic
moment of a free electron (ge). The current value is ge = 2.0023193043617 ± 1.52 ppt.93
The EPR spectra for the reaction of pCN with Hcy was measured and an unpaired
electron was found as expected, with g = 2.002301 (Figure 26-B). A single isotropic
signal was measured, denoting symmetry in the electron wave function.94 The signal had
a broad peak to peak linewidth (Δβ) of ~ 10 G.
More interestingly, pCN without Hcy produced the same EPR signal, but with
greater amplitude. The amplitude is proportional to the concentration of resonating
paramagnetic species in the sample.94 Therefore, the pCN probe was able to generate
radicals in the absence of a reducing agent such as Hcy. Furthermore, the concentration
of radical species represented by the EPR spectra was apparently diminished by the
presence of Hcy. Sun and Yang observed a similar broad, single isotropic signal and
attributed it to the localization of electrons in P2 type pimerization while assigning
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spectra with hyperfine coupling to P2•+ and monomeric radical species.82 However, P2
type pimerization is largely undetectable with standard EPR spectroscopy methods
because the spins of the two interacting electrons pair to become diamagnetic.81, 83 Single
isotropic signals with large Δβ and unresolved hyperfine interactions can result from
signal averaging of multiple paramagnetic species interacting with multiple nuclei.94 The
diminished signal amplitude of pCN radicals in the presence of Hcy actually
corresponded to an increase in radical species and subsequent formation of EPR silent P2
type pimers. Radicals were not observed at pH 6.0, providing further evidence that
cleavage of the probes’ labile hydrogens may play a role in the reaction mechanism
(Figure 26-C).
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C

D

Figure 26. EPR signals. 120 scans (~20 min) using x-band frequency ν = 9.754434 GHz
and Hall Field β0 = 3480.651 G, in 100 mM phosphate buffer. (A) 20.0 mM pCN at pH
8.0, g = 2.002312, Δβ = ~10 G. (B) 20.0 mM pCN with 20 mM Hcy at pH 8.0, g =
2.002301, Δβ = ~10 G. (C) 20.0 mM pCN at pH 6.0. (D) 20.0 mM Hcy at pH 8.0.
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4.4 1HNMR of reaction products
1

HNMR of the reaction between pCN and Hcy revealed shifting of the viologen

hydrogens upfield (Figure 27). This was consistent with reduction of the viologen
subunits since the addition of electron density would lead to greater shielding and a
diamagnetic shift. Convergence of the interior hydrogens ‘b’ and ‘c’ indicated
delocalization of the π-system across the originally isolated pyridine rings. Hydrogens at
positions ‘a’ and ‘d’ did not fully converge due to asymmetry of the substituents.

pCN
pCN + Hcy
a

d

a

c

b

c

d

b

Figure 27. 1HNMR of viologen hydrogens shifting. 80:20 D2O:H2O with 100 mM
phosphate buffer pH 8.0 and DSS standard. Blue line: pCN probe only. Red line:
reaction of 20.0 mM pCN with 20.0 mM Hcy after 4 hr.
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Figure 28. 1HNMR of potential Hcy oxidation products. 80:20 D2O:H2O with 100 mM
phosphate buffer pH 8.0 and DSS standard. From bottom: (lane 1) homocysteic acid,
(lane 2) homocysteinesulfinic acid, (lane 3) homocystine, (lane 4) Hcy control, (lane 5)
reaction of 20.0 mM pCN with 20.0 mM Hcy after 4 hr.
1

HNMR spectra of the available Hcy oxidation products were compared with the

Hcy peaks of the reaction mixture (Figure 28). Homocystine (28), homocysteinesulfinic
acid (25), and homocysteic acid (26) were ruled out as potential reaction products since
they did not produce the same shifts. Homocysteine thiolactone (29) (not shown) was
also rule out by comparison of the 1HNMR peaks. A notable feature in the 1HNMR
spectrum of the pCN and Hcy reaction mixture is the presence of the α-amino carbon
hydrogen at 4.3 ppm. The peak for the α-amino carbon hydrogen in the reaction mixture
integrated for a full hydrogen relative to the β and γ positions which integrated for two
hydrogens each. If the probe was being reduced by the α-amino carbon centered radical
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of Hcy, the resulting α-amino carbocation of Hcy (1c) would be stabilized by resonance
to form the Hcy iminium species (1d) and a hydrogen would not be present at the α
position. Since this is not the case, it seems unlikely that pCN was reduced by electron
transfer directly from the α-amino carbon centered radical.
Instead, Hcy may facilitate radical propagation in general by interconversion of
the of thiyl radical (1a) with the α-amino carbon centered radical (1b). Sterics and
resonance stabilization deter geminate recombination and radical disproportionation,
leading to an increase in the residence time of the carbon centered radical. The uniquely
facile intramolecular HAT of Hcy provides a convenient rout to “store” and “regenerate”
the thiyl radical (Figure 29). This allows greater diffusion and accumulation of radical
species in solutions that contain Hcy.

Figure 29. Interconversion of Hcy analyte species to reactive thiyl radical (1a) and
thiolate anion (1e).
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4.5 Mechanism of the bridged bis-nitrile viologen probes
Electron deficient viologen dication moieties will readily accept an electron by
reduction. The mechanism of Hcy detection based strictly on reduction of the probe is
represented by the probe species sequence 12 → 12c → 12d where 12c is the diagnostic
species with λabs = 540 nm (Figure 30). If 12c is a required intermediate en route to the
fully oxidized yellow species, 12d; then the prevalence of 12d should also correspond to
the reduction potential of analytes. However, the faster rate of increase at λabs = 413 nm
observed with blank solutions of probe compared to solutions with aminothiol present
contradicted this mechanism (Figure 19-B).
The viologen dication moieties will also accept electrons from neighboring atoms
provided they can be delocalized from the donor. Heterolytic cleavage of the methylene
C-H bond by anions in solution produces an iminium intermediate that conjugates the
viologen with the nitrile substituent. The new sp2 center, positioned between two
electron withdrawing groups, is electrophilic and susceptible to nucleophilic addition. A
variety of transient anions in solution can interact with the probe as a base (:B -) or as a
nucleophile (:Nu-). Since the pKa of the Hcy thiol group is just 2 pH units greater than
the buffered reaction solution (Hcy S-H pKa = 10.0), the Hcy thiolate anion (1e) is an
ideal candidate to drive the equilibrium of these reactions towards products. However,
anion interactions with the probe following the sequence 12 → 12b → 12f do not
produce a radical species with λabs = 540 nm. Products 12b and 12f are expected to
appear yellow from absorptions near 400 nm due to the π-system conjugation. Under
certain reaction conditions, peak overlap in this region of the spectrum could be discerned
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and an additional absorbtion peak was found with max λabs = 370 nm (see Appendix A,
Figure 48).
Homolytic cleavage of the probe C-H bond has the potential to result in the red
radical probe species (12 → 12a) or disproportion the probe radical to the yellow species
(12c → 12b). Similar to reactivity with anions, a variety of transient ROS in solution can
propagate a radical to the probe by HAT. However, the propensity for thiols to form
relatively stable thiyl radicals makes the thiyl radical a convenient agent for HAT from
the probe. Thiol pKa values for Hcy, Cys, and GSH (pKa = 10.0, 8.33, and 9.12
respectively)22, 56-57 give the order of thiolate anion/thiol ratio for theses analytes in
solutions buffered at pH 8.0 as Cys > GSH > Hcy by the Henderson–Hasselbalch
equation. This relationship, interpreted as order of thiolate anion stability, insinuates a
slower rate of thiyl radical formation for Cys because the sulfur atom of Cys is more
effective at withdrawing electrons than GSH or Hcy.95 The comparatively higher rate of
thiyl radical (1a) formation for Hcy follows the same argument. Facile intramolecular
HAT for Hcy provides additional pseudo-stability for Hcy radical species by partitioning
the residence time of the analyte radical between the thiyl radical (1a) and resonance
stabilized α-amino carbon radical (1b). The relative stability of 1b increases analyte
radical half-life and the ability to regenerate the 1a radical from ancillary ‘storage’ results
in a greater concentration of reactive thiyl species for Hcy.
Besides disproportionation of the probe, contributions to the decline of λabs = 540
nm observed over extended periods of time can come from the addition of a radical
species, such as the Hcy thiyl radical (1a), which results in radical termination (12a →
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12g). Conversely, adduct formation by radical addition can result in an increase of λabs =
540 nm by reactions of the form (12b → 12e). Various combinations of radical addition,
nucleophilic addition, redox interactions, and proton transfers are feasible which would
account for the observed absorbance changes as the reaction progresses. A singular
reaction pathway is unlikely as speciation would be governed by equilibria and highly
dependent on the reaction conditions. The relationship between mixed competitiveconsecutive and parallel reactions depicted in the flow diagram of Figure 31 summarizes
the dynamic evolution of probe products; however, only one arm of the bridged probe is
represented. As one side of the molecule reacts, the chemistry of the local environment
changes and effects reactivity on the opposing side.
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Figure 30. Reactive site of N-substituted-N’-(cyanomethyl)viologen probes.
The reaction mechanisms in Figure 30 are represented with forward reaction
arrows and insinuate bimolecular transitions states. However, equilibrium and the
possibility of unimolecular transitions states such as those of E1 and Sn1 type reactions
are also implied. Since the pKa of the probe is lower than the pH of the buffered reaction,
some uncoordinated proton dissociation would be expected. See Appendix A, Figure 52
for data indicating the rate of increase at λabs = 413 nm is approximately first order with
respect to pCN. This reinforces the likelihood of a unimolecular transition state en route
to the product(s) responsible for λabs = 413 nm.
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Figure 31. Dynamic evolution of probe-analyte adducts. Colored boxes assign the
predicted contribution of that compound to the perceived solution color and measured
λabs. Red box: λabs ≈ 540 nm. Yellow box: λabs ≈ 400 nm.
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4.5 Mass spectra of reaction products
1

HNMR data discussed in Section 4.4 indicated the reaction between pCN and

Hcy had gone to completion after 4 hours, resulting in a conspicuous major product for
the pCN probe and a lone product for the fully converted Hcy analyte. It was thought
that the large downfield shift of the hydrogen α to the amine of Hcy could have been
caused by oxidation of the amine to an electron withdrawing nitrosamine (18) or nitro
group (22). However, ions of these Hcy products as well as the other potential oxidation
products shown in Figure 32 were not found in the mass specta of the reaction mixture.
Mass spectra of the reaction were obtained by two different ionization methods,
electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI).
Refer to Section 8.3 for method details. Peaks in the spectra that were close to potential
products are listed in Table 1. A peak found in the ESI spectrum at 196.08 Da was close
to the [M-H+2Na]+ ions of oxidation products 21, 22, or 23 which were calculated to be
196.01 Da. However, better mass accuracy is obtained from probe fragment ions 38, 39,
and 40 with m/z = 196.08, 196.09, and 196.09 Da respectively (Figure 33). There were
also several peaks with masses close to various ions of oxidation product 27: [M+H+K]2+
138.02 Da calculated, 138.08 Da by ESI; [M+2K]2+ 156.50 Da calculated, 157.06 Da by
ESI; [M+Na]+ 259.07 Da calculated, 259.10 Da by ESI, 259.14 Da by MALDI.
However, these peaks also had better mass accuracy with probe fragments 32, 33, 34, 44,
and 45 with m/z = 138.06, 157.06, 157.08, 259.11, and 259.12 Da respectively.
Compound 29 had an ion mass similar to a peak found in the spectra: [M+2Na]2+ 172.51
Da calculated, 172.07 or 172.93 Da by MALDI. Probe fragments 36 and 37 with
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calculated m/z = 172.06 and 173.07 Da would more accurately account for these peaks.
Peaks found which were similar to those expected for ions of oxidation products 26 and
28 were also listed in Table 1, though neither was considered to represent the Hcy
reaction product based on previous elimination by 1HNMR comparisons (Figure 28).

Figure 32. Structures of Hcy oxidation products.
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Table 1. Various salts and ionization states of Hcy oxidation products with potential mass
spec signal. Calculated m/z for ionic species indicated by parenthesis. NF = not found;
E = peak found in MS obtained by electrospray ionization; D = peak found in MS
obtained by Matrix-assisted laser desorption/ionization. Rows that are shaded correspond
to compounds which have been ruled out as reaction products based 1HNMR.
[M+H]+

#
1

Mass
135.04

19
20
21

117.03
149.01
151.03

22

151.03

23

151.03

24
25
26

165.01
167.03
183.02

27

236.08

28

268.06

29

300.05

#
27

[M+2H]2+

28

[M+K]+
(174.00)
173.98 E

[M-H+2K]+

[M+Na]+

[M-H+2Na]+

[M-H+K+Na]+

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF

NF
NF
NF

NF
NF
NF

NF
NF
NF

NF

NF

NF
NF
NF
(259.95)
260.15 D

NF
(196.01)
196.08 E
(196.01)
196.08 E
(196.01)
196.08 E
NF
NF
NF

NF

NF

NF

NF

NF

NF

NF
NF

NF
NF

NF
NF

NF
NF

NF
NF

NF
NF
NF

NF

[M+H+K]2+
(138.02)
138.08 E

NF

NF

[M+2K]2+
(156.50)
157.06 E
(172.49)
172.93 D

NF

NF

NF

NF
(259.07)
259.14 D
259.10 E
(291.04)
291.15 E
NF

NF
NF
NF
NF
NF

[M+H+Na]2+

[M+2Na]2+

[M+K+Na]2+

NF

NF

NF

NF
(156.52)
157.06 E
(172.51)
172.07 D
172.93 D

NF

29

NF
NF

The only ion peak in Table 1 that did not have a corresponding probe fragment
with better mass accuracy belonged to non-oxidized Hcy (1) [M+K]+ 174.00 Da
calculated, 173.98 Da by ESI. This signal had low relative abundance and could have
been produced by fragmentation during analysis. Most importantly, the ions responsible
for the base peaks of both spectra (314.09 Da by ESI and 314.12 by MALDI) was
determined to arise from the parent ion 49 and related isoelectric tautomers such as ion
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48, each with m/z = 314.12 Da. A comprehensive list of ions identified in the mass
spectra can be found in Appendix A, Table 3 with associated structures in Figure 53 and
Figure 54. These ions confirm the identity of the Hcy reaction product shown in Lane 5
of Figure 28 as a thioether adduct with the pCN probe. The 1HNMR peak shifts for the
Hcy adduct, particularly the downfield shift observed with the α-amino proton, was
attributed primarily to the extreme chemical environment localized to the probe with
some inductive contributions through the thioether linkage. Ions with distinct m/z
corresponding to Hcy adducts bonded by a secondary amine, ether, ester, or at the
carbonyl carbon were not found in the mass spectra.
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Figure 33. Structures of selected ions identified in the mass spectra of the pCN and Hcy
reaction mixture (for additional structures see Appendix A, Figure 53, Figure 54, and
Table 3).
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Chapter 5: Preliminary survey of bridged bis-coumarin viologens
Analogs of the bridged viologen probe were synthesized by replacing the
methylene-nitrile substituent with 3-acetylcoumarin (Figure 34). Coumarin is a common
chromophore scaffold used in fluorescent brighteners and laser dyes due to its tunable
absorbance and fluorescence properties.96 Molecular modeling showed ordered stacking
of the two fluorescent acetylcoumarin moieties for the para-bridged bis-coumarin
viologen (pAC, 15) in its lowest energy conformation. The stacked fluorophore were
predicted to quench each other in this conformation due to the small separation, ~3.3 Å.
Analyte interactions with the probes would increase the distance between the
fluorophores and lead to changes in the fluorescence spectrum. These conformational
changes could be induced by supramolecular interactions, such as the binding of GSH
within the cavity of pAC, or by reactions with the probe, such as the straightening and
rotation of pyridine rings upon reduction of the viologens.

Figure 34. Structures of the bridged bis-coumarin viologen probes. Positional isomers:
oAC (13) = ortho, mAC (14) = meta, and pAC (15) = para.
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Fluorescence excitation (λex) and emission (λem) wavelengths for coumarins
similar in structure to the acetylcoumarin substituent used here have been reported near
λex/λem = 320/440 nm.97 Each of the bridged bis-coumarin viologen probes were found to
fluoresce at λex/λem = 345/460 nm in the absence of aminothiol analyte. This blueshifted
λex/λem was assigned to the acetylcoumarin substituents and monitored for spectral
changes with the addition of aminothiol analytes. Preliminary trials using mAC or pAC
in phosphate buffer with analytes Hcy, Cys, and GSH did not result in a selective change
in intensity at λem = 460 nm for any particular analyte.

A

λex

λex

B

λex

λem [nm]
C

λex

D

Figure 35. Fluorescence of the acetylcoumarin was quenched with isomer oAC. EEM
spectra of 50.0 µM probe after 1 hr in 80.0 mM phosphate buffer at pH 6.0 without
analyte. λem intensity did not change significantly over time. Max λex/λem = 345/460 nm.
(A) oAC. (B) mAC. (C) pAC. (D) 2D view of mAC topology.
For the oAC probe fluorescence at λex/λem = 345/460 nm was significantly
quenched, regardless of the presence of aminothiols (Figure 35). A survey of λex revealed
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fluorescence at λex/λem = 405/500 nm that was found to have pH dependent selectivity for
Cys (Figure 36). Probes mAC and pAC did not fluoresce at these wavelengths under the
same conditions. However, a selective fluorescence response in the presence of Hcy was
found for mAC at λex/λem = 485/510 nm. With mAC, the rate of increase at λem = 510 nm
in the presence of Hcy did not abate during the first hour of data collection, requiring
more than 12 hrs to level-off (Figure 37).

A

B

Figure 36. λex/λem = 405/500 nm. 50.0 µM oAC in 80.0 mM phosphate buffer with 200
µM of the indicated thiol. (A) λem = 500 nm at pH 8.0 over 35 min. (B) pH dependent
response to analytes at 35 min time point. Figure 56 in Appendix A provides an example
of the topography for this peak.

A

B

λem [nm]

λex

Figure 37. λex/λem = 485/510 nm. 50.0 µM mAC in 80.0 mM phosphate buffer pH 6.0
with 200 µM of the indicated thiol. (A) λem = 510 nm over 12 hrs. (B) Surface plot of
Hcy at 12 hr point. See Appendix A, Figure for surface plots of the blank, Cys, and
GSH.
Curiously, similar UV/Vis absorbance spectra were observed for all three
positional isomers of the probe. In phosphate buffer at pH 8.0 the absorbances were
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essentially stable over the course of an hour; only negligible deviations were measured.
The strongest absorbance was increasing over time with a max λabs = 260 nm. There was
an isobestic point at 300 nm which enunciated a shoulder vanishing from side the main
peak. Isobestic points at 405 and 452 nm marked the inflections of a small increase at
λabs = 420 nm and another decrease at λabs = 540 nm. Figure 38 illustrates the minor
changes in absorbance observed for oAC (with and without Cys analyte) under the same
reaction conditions that produced a fluorescence response for Cys at λex/λem = 405/500
nm nearly 50 times greater than the probe without analyte. Contrary to what would be
expected, λex = 405 nm for oAC is at a low absorbance isobestic point in the UV/Vis
spectra. Although, absorbance in this area was observed to increase rapidly with the
bridged nitrile analogs (Figure 19).
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A

B

A

B

A

B

Figure 38. Absorbance spectrum of 50.0 µM oAC in 80.0 mM phosphate buffer pH 6.0
over 1 hr with a scan every 2 min. Expanded views retain the same label: (A) without
analyte. (B) with 200 µM Cys.
Another interesting aspect of the absorbance spectra of the bridged bis-coumarin
viologens was the decrease at λabs = 540 nm that corresponded to λabs of the diagnostic
peak for the bridged bis-nitrile viologen probes. Furthermore, the bridged bis-nitrile
viologen probes were found to fluoresce at λex/λem = 480/510 nm. This fluorescence
corresponded to λex/λem of the mAC probe, implicating the viologen moieties as the
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fluorophore in mAC and providing a possible explanation for the selective response
observed with Hcy (Figure 57).
Coumarin chromophores are known to act as radical initiators and
photosensitizers.96, 98-100 Since λem ≈ 510 nm for the bridged bis-nitrile viologens, mAC,
and oAC; the fluorescence of oAC might be explained by photosensitization of the
viologen by acetylcoumarin. A charge transfer mechanism of fluorescence from the
acetylcoumarin chromophores to the viologen of oAC before emission of a photon is
supported by the quenching of acetylcoumarin fluorescence at λem = 460 nm, just 20 nm
away from λex observed for the viologens. Close spatial arrangement of the oAC probe
arms might allow this energy gap to be overcome.
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Chapter 6: Conclusions
Fluorometric and colorimetric responses of the bridged viologen probes to
aminothiol analytes are dependent on reaction conditions such as pH, buffer identity,
ratio of solvent, ionic strength of the solution, and reaction time. Compared to the other
aminiothiols, Cys and GSH, facile interconversion of Hcy between its thiyl radical and αamino carbon centered radical species allows greater accumulation of analyte radical
species and subsequent propagation to the probe. The resulting radical cations of the
bridged bis-nitrile probes are stabilized by pimerization with λabs ≈ 540 nm attributed to
P2 type pimers. Biological concentrations of Hcy can be detected selectively in
deproteinized plasma buffered with phosphate to pH 8.0 by measuring the increase in λabs
= 540 nm of the pCN probe (LOD = 2.17 µM and LOQ = 6.10 µM). The mechanism of
reactivity between pCN and Hcy also involves cleavage of the probe’s labile C-H bond
vicinal to the nitrile group, followed by either radical or nucleophilic addition of Hcy to
form the thioether adduct.
Differences in colorimetric response of for positional isomers of the xylene bridge
were subtle with the bridged bis-nitrile viologen probes. The short ortho linkage of oCN
led to a slight increase in reactivity and broadening of the diagnostic λabs accompanied by
a 10 nm redshift. Preliminary fluorometric results with the bridged bis-coumarin analogs
revealed different λex/λem profiles for each positional isomer and pH dependent responses
to analytes. Selective increases in λem were observed for Hcy using mCN at pH 6.0 with
λex/λem = 485/510 nm and for Cys using oCN at pH 8.0 with λex/λem = 405/500 nm. These
responses did not correspond to the expected λex/λem for acetylcoumarin, suggesting
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involvement of the viologen moieties in the fluorescence mechanism. Thorough studies
of the bridged bis-coumarin viologen probes concerning optimization of the reaction
conditions, elucidation of the mechanism, and assessment of tolerance to interferences
will provide crucial information for the next generation of fluorophore-viologen probes.
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Chapter 7: Experimental Methods
7.1 Reaction schemes
The synthetic strategy for target compounds oCN (10), mCN (11), pCN (12),
mAC (14), and pAC (15) was adapted from the method used by Geuder et al. to
synthesize bridged viologen compounds (Figure 39 and Figure 40).77 This method was
low yielding in the final alkylation step. Attempts to optimize reactant ratios and reflux
time gave similar results. The final alkylation failed repeatedly for the target compound
oAC (13). An unidentified product was consistently isolated from the reaction mixture in
high purity and yield. The total 1HNMR integration did not agree with the target
compound but did indicate a possible coumarin dimer. 96 Presumably, sterics would not
allow the attachment of a second large acetylcoumarin moiety to a viologen bridge
constrained in the ortho position. By reversing the order of the reaction scheme, the
synthesis of oAC was achieved more efficiently and with a higher yield than the other
isomers (Figure 41). BNV (16) was synthesized expediently and with high yield using
microwave irradiation by adapting the method used by Lamberto et al. to synthesize
asymmetrically substituted viologens (Figure 42).101 A mixture of Br- and PF6- salts
precipitated from the reaction solvent. The first crop of BNV filtered from the solvent
was water soluble. After reducing the solvent volume under vacuum, a second crop of
BNV was obtained that had the same 1HNMR spectra and reactivity as the first batch, yet
was only slightly soluble in water. It was thought that the first crop had a higher ratio of
PF6- counterions which made it less soluble in the reaction solvent and more soluble in
water.
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Figure 39. Reaction scheme for bridged viologen bis-nitrile compounds. Using
isomerically pure starting material give an isomerically pure product. Overall yields:
18% oCN (10), 21% mCN (11), and 36% pCN (12).
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Figure 40. Reaction scheme for meta- and para- bridged viologen bis-coumarin. This
scheme failed repeatedly with for the ortho isomer, target compound oAC. Overall
yields: 30% mAC (14) and 32% pAC (15).

Figure 41. Reaction scheme for oAC (13). 59% overall yield.
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Figure 42. Reaction scheme for BNV (16). 59% overall yield.
7.2 Protocols
The procedure for screening in buffer was performed as follows:
Reduced Hcy, Cys, and GSH with purities ≥98.0% were purchased from SigmaAldrich. Stock solutions of the probe, homocysteine, cysteine, glutathione were prepared
fresh using ultra-pure water (UPW). Buffer solutions were prepared with UPW and were
kept no longer than a month. Mixing of the solutions was carried out in 4 mL sample
vials. The volumes of each stock solution needed to achieve the appropriate
concentrations in 1.00 mL of total volume were calculated. The volume of UPW
necessary to fill the remainder of the total sample volume was also calculated. Then the
initial order of addition of to an empty sample vial was: UPW, stock buffer, and stock
aminothiol solution respectively. Without delay, the vial was immediately vortexed for
~3 sec to mix the buffer and aminothiol; the probe solution was added to initiate the
reaction; and the vial vortexed a second time for ~5 sec to ensure a homogeneous
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solution. The solution was either immediately pipetted into a cuvette for
spectrophotometry or left in the vial to observe color changes visually.
Samples which contained deproteinized plasma were prepared by the same
procedure for screening in buffer vide supra, except the 4 mL sample vial initially
contained lyophilized deproteinized plasma. To obtain deproteinized plasma, lyophilized
bovine plasma purchased from Sigma-Aldrich was reconstituted with UPW to 1/3 of the
reconstitution volume. Two equivalents of acetonitrile (2/3 of the reconstitution volume)
were added and the solution was vortexed for 10 min. The solution was allowed to stand
for an additional 10 min before centrifuging at 4000 rpm for 30 min to pellet the proteins.
The decanted supernatant was aliquoted into sample vials and re-lyophilized. The vials
were then sealed and stored in a refrigerator.
7.3 Instrumentation
Absorbance measurements were performed using a Cary 50 UV/Vis
Spectrophotometer with Scan Software Version: 3.00(303). The automated speed was set
to normal. Fluorescence measurements were performed with Cary Eclipse Fluorometer
using Scan Software Version: 1.1(132). Typical settings were Ex. slit: 5 nm, Em. slit: 5
nm, scan rate: 857.14 nm/min, data interval: 2.5000 nm, averaging time: 0.1750 sec,
PMT voltage: high (900W), Ex. increment: 5 nm, filters: 0.1 and 0.5 OD. EPR spectra
were obtained using a Bruker e-scan instrument with WinEPR Acquisition Software
version 4.40 rev. 05. 1994-2007 Bruker BioSpin GmbH; X band frequency: 9.754229
GHz; Hall Field β0 = 3480.651247 G; attenuation: 2 dB; and power: 31.55 mW.
Microwave reactions were irradiated while stirring in air cooled sealed vials stirring using
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a Biotage Initiator with absorption level set to normal. ESI-FTMS +p for the
identification of synthetic products was done in 50% MeOH on a ThermoElectron LTQOrbitrap Discovery high resolution mass spectrometer with Accela HPLC. Reaction
products of 20.0 mM pCN with 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0 were
analyzed by ESI-TOF-MS and MALDI-TOF-MS, both in positive ion mode. The ESI
method was performed by diluting the sample in MeOH with 0.1% formic acid before
injecting into a Waters Micromass Q-TOF micro instrument. The MALDI method R+ of
reaction solution was performed using an α-Cyano-4-hydroxycinnamic acid matrix on an
ABI 4800 MALDI TOF-TOF analyzer.
7.4 Synthetic Methods
1,4-bis(N-methylene-4,4’-bipyridinium)benzene (67a): 4,4’-Bipyridine 61 (3.33 g,
21.3 mmol) was brought to refux in 25 mL of MeCN. 1,4-bis(bromomethyl)benzene
64 (1.00 g, 3.79 mmol) dissolved in 70 mL of MeCN was added dropwise over 1 hr.
Reflux was maintained for an additional 5 hr, after which the precipitate was hot
filtered and the filter cake washed with MeCN. The yellow solid was dried under
vacuum overnight to give 2.08 g (3.61 mmol, 95% yield) of compound 67a as the
bromide salt. 1H NMR (400 MHz, D2O) δ 9.09 (4 H, d), 8.81 (4 H, d), 8.47 (4 H, d),
7.95 (4 H, d), 7.67 (4 H, s), 5.98 (4 H, s). 13C NMR (101 MHz, D2O) δ 157.16,
152.76, 147.71, 145.17, 137.16, 132.84, 129.03, 125.24, 66.39.
Anionic exchange of bromide salt (67a) to hexafluorophosphate salt (67b):
Compound 67a (2.00 g, 3.47 mmol) was dissolved in 20 mL of water with stirring.
Some isomers required gentle heating < 60 ᵒC. Stirring was continued as 15 mL of a
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1.00 M aqueous NH4PF6 was dipped in. The precipitated solid was filtered, washed
with water, and air dried. The yield of 67b was quantitative (2.45 g, 3.47 mmol).
Para-bridged bis-CN viologen (pCN) (12): Bromoacetonitrile (2.00 mL, 28.71 mmol)
was brought to reflux in 20 mL of MeCN. Compound 67b (2.00 g, 2.83 mmol)
dissolved in 100 mL of MeCN was added dropwise in over 1 hr. Reflux was
maintained for an additional 12 hr. The precipitate was filtered and washed
thoroughly with MeCN. The corresponding meta and ortho isomers were found to be
increasingly hydroscopic and had a tendency to become gooey if air was pulled
through the filter cake too long. The resulting yellow solid was dried under vacuum
overnight to give 1.01 g of compound 12 as the mixed salt (1.07 mmol, 38% reaction
yield, 36% overall yeild), which was stored under argon, in an amber vial, and in a
desiccator at -80 ᵒC. 1H NMR (400 MHz, D2O) δ 9.34 (4 H, d), 9.23 (4 H, d), 8.71 (4
H, d), 8.63 (4 H, d), 7.67 (4 H, s), 6.07 (4 H, s), 6.03 (4 H, s). 13C NMR (101 MHz,
D2O) δ 154.76, 152.73, 148.91, 148.50, 136.78, 133.13, 130.38, 130.18, 115.42,
66.96, 50.82. FTMS +p ESI: m/z, calculated: 247.1104, found: 247.1102 [M–2H]2+;
calculated: 263.1235, found: 263.1232 [M+MeO]2+.
1,3-bis(N-methylene-4,4’-bipyridinium)benzene (66a): 4,4’-Bipyridine 61 (1.68 g,
10.76 mmol) was brought to reflux in 20 mL of MeCN. 1,3bis(bromomethyl)benzene 63 (1.00 g, 3.79 mmol) dissolved in 20 mL of MeCN was
added dropwise in over 1 hr. Reflux was maintained for an additional 5 hr, after
which the precipitate was hot filtered and the filter cake washed with MeCN. The
yellow solid was dried under vacuum overnight to give 2.10 g (3.64 mmol, 96%
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yield) of compound 66a as the bromide salt. 1H NMR (400 MHz, D2O) δ 9.00 (4 H,
d), 8.73 (4 H, d), 8.40 (4 H, d), 7.85 (4 H, d), 7.64 (3 H, s), 7.31 (1 H, s), 5.94 (4 H,
s). 13C NMR (101 MHz, D2O) δ 152.77, 147.88, 144.90, 137.15, 133.50, 132.94,
130.95, 128.86, 125.11, 66.41.
Meta-bridged bis-CN viologen (mCN) (11): Anionic exchange of bromide salt (66a) to
hexafluorophosphate salt (66b) and subsequent transformation to the mixed salt of
compound 11 was done by the same procedure given for compound 67. Overall yield
for the reaction scheme of compound 11 was 21%. 1H NMR (400 MHz, D2O) δ 9.35
(4 H, d), 9.24 (4 H, d), 8.72 (4 H, d), 8.64 (4 H, d), 7.78 (1 H, s), 7.68 (3 H, s), 6.08 (4
H, s), 6.04 (4 H, s). 13C NMR (101 MHz, D2O) δ 154.77, 152.69, 148.87, 148.46,
136.26, 133.71, 133.67, 132.92, 130.40, 130.21, 115.41, 66.99. FTMS +p ESI: m/z,
calculated: 262.1157, found: 262.1157 [M-2H+MeO]2+.
1,2-bis(N-methylene-4,4’-bipyridinium)benzene (65a): 4,4’-Bipyridine 61 (1.50 g,
9.58 mmol) was brought to refux in 10 mL of MeCN. 1,2-bis(bromomethyl)benzene
62 (1.00 g, 3.79 mmol) dissolved in 10 mL of MeCN was added dropwise in over 1
hr. Reflux was maintained for an additional 3 hr, after which the precipitate was hot
filtered and the filter cake washed with MeCN. The yellow solid was dried under
vacuum overnight to give 2.17 g (3.77 mmol, 99% yield) of compound 65a as the
bromide salt. 1H NMR (400 MHz, D2O) δ 8.79 (4 H, d), 8.57 (4 H, d), 8.24 (4 H, d),
7.85-7.82 (2 H, m), 7.80-7.77 (2 H, m), 7.66 (4 H, d), 6.13 (4 H, s). 13C NMR (101
MHz, D2O) δ 156.81, 152.75, 147.26, 143.76, 136.93, 134.95, 133.44, 128.70,
124.78, 64.21.
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Ortho-bridged bis-CN viologen (oCN) (10): Anionic exchange of bromide salt (65a) to
hexafluorophosphate salt (65b) and subsequent transformation to the mixed salt of
compound 10 was done by the same procedure given for compound 67. Overall yield
for the reaction scheme of compound 10 was 18%. 1H NMR (400 MHz, D2O) δ 9.36
(4 H, d), 9.20 (4 H, d), 8.74 (4 H, d), 8.69 (4 H, d), 7.68-7.66 (2 H, m), 7.41-7.39 (2
H, m), 6.23 (4 H, s), 6.08 (4 H, s). 13C NMR (101 MHz, D2O) δ 154.67, 153.13,
148.94, 148.71, 134.14, 133.61, 133.39, 130.45, 130.39, 130.32, 115.41, 64.02.
FTMS +p ESI: m/z, calculated: 262.1157, found: 262.1158 [M-2H+MeO]2+.
Para-bridged bis-coumarin viologen (pAC) (15): 3-(bromoacetyl)coumarin 68 (2.00 g,
7.49 mmol) was brought to reflux in 20 mL of MeCN. Compound 67b (0.500 g,
0.708 mmol) dissolved in 100 mL of MeCN was added dropwise in over 1 hr. Reflux
was maintained for an additional 12 hr. The precipitate was filtered warm and
washed thoroughly with MeCN. The resulting green solid was dried under vacuum
overnight to give 0.301 g of the target compound as the mixed salt (0.242 mmol, 34%
reaction yield, 32% overall yield). 1H NMR (400 MHz, DMSO) δ 9.65 (4 H, d), 9.27
(4 H, d), 9.02 (2 H, s), 8.91 (4 H, d), 8.89 (4 H, d), 8.13 (2 H, d), 7.89 (2 H, t), 7.79(4
H, d), 7.62 (2 H, d), 7.53 (2 H, t), 6.45 (4 H, s), 6.06 (4 H, s). 13C NMR (101 MHz,
DMSO) δ 187.75, 158.66, 154.85, 149.79, 149.27, 149.18, 147.12, 145.93, 135.99,
135.36, 131.58, 129.80, 127.27, 126.36, 125.56, 121.08, 117.93, 116.47, 68.94, 62.62.
Meta-bridged bis-coumarin viologen (mAC) (14): Attachment of the acetylcoumarin
68 moiety to the meta isomer of the viologen bridge 66b was accomplished by the
same procedure given for compound 15. The target compound was isolated as a
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yellow solid which was stored at rt for an extended period of time without any
apparent degradation in its optical properties. Overall yield: 30%. 1H NMR (400
MHz, DMSO) δ 9.67 (4 H, d), 9.28 (4 H, d), 9.02 (2 H, s), 8.95 (4 H, d), 8.92 (4 H,
d), 8.13 (2 H, d), 8.05 (1 H, s), 7.89 (2 H, t), 7.70 (2 H, d), 7.60 (3 H, m), 7.53 (2 H,
t), 6.46 (4 H, s), 6.08 (4 H, s).

13

C NMR (101 MHz, DMSO) δ 187.77, 158.67,

154.85, 149.81, 149.28, 149.16, 147.13, 145.95, 136.00, 135.06, 131.58, 130.13,
129.81, 129.66, 127.26, 126.40, 125.57, 121.08, 117.93, 116.48, 68.96, 62.74.
1-(2-oxo-2-(2-oxo-2H-chromen-3-yl)ethyl)-[4,4'-bipyridin]-1-ium (69a): 4,4’Bipyridine 61 (0.750 g, 4.80 mmol) and 3-(bromoacetyl)coumarin 68 (0.500 g, 1.87
mmol) were dissolved in 40 mL of acetone and stirred at rt for 3 hrs. The precipitate
was filtered and washed with acetone (0.658 g, 1.55 mmol, 83% yield). 1H NMR
(400 MHz, DMSO) δ 9.11 (2 H, d), 9.02 (1 H, s), 8.91 (2 H, d), 8.76 (2H, d), 8.12 (1
H, d), 8.09 (2 H, d), 7.89 (1 H, t), 7.61 (1 H, d), 7.52 (1 H, t), 6.36 (2 H, s).
Ortho-bridged bis-coumarin viologen (oAC) (13): Anionic exchange of bromide salt
(69a) to hexafluorophosphate salt (69b) and subsequent transformation to the mixed
salt of compound 13 was performed with quantitative yield by the same procedure
given for compound 67. After thorough drying, 0.500g (1.02 mmol) of the
hexafluorophosphate salt (69b) was brought to reflux in 20 mL of MeCN. A solution
of 1,2-bis(bromomethyl)benzene (0.135 g, 0.512 mmol) in 20 mL of MeCN was
added over 1 hr and reflux was maintained for an additional 3 hrs. The precipitate
was filtered and washed with MeCN to provide 0.451 g (0.364 mmol, 71% reaction
yield, 59% overall yield) of the target compound (13) as a green solid. 1H NMR (400
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MHz, DMSO) δ 9.57 (4 H, d), 9.29 (4 H, d), 9.04 ( 2 H, s), 8.95 (4 H, d), 8.93 (4 H,
d), 8.13 (2 H, d), 7.89 (2 H, t), 7.60 (2 H d), 7.57 (2 H, m), 7.53 (2 H, t), 7.35 (2 H,
m), 6.47 (4 H, m), 6.42 (4 H, m).

13

C NMR (101 MHz, DMSO) δ 187.78, 158.65,

154.84, 149.86, 149.37, 149.17, 147.17, 146.27, 136.01, 132.73, 131.57, 130.19,
129.69, 127.23, 126.39, 125.56, 121.04, 117.92, 116.46, 68.99, 60.29.
1-benzyl-[4,4'-bipyridin]-1-ium (71a): Benzyl bromide 70 (0.500 g, 2.92 mmol) and
4,4’-bipyridine 61 (0.913 g, 5.85 mmol) were dissolved in 10.0 mL of DCM and
irradiated in a Biotage Initiator on normal power for 60 min at 60 ᵒC. The pale
yellow bromide salt precipitate (0.862 g, 2.64 mmol, 90% yield) was filtered and
washed with acetone. 1H NMR (600 MHz, DMSO) δ 9.42(2 H, d), 8.87 (2 H, d),
8.67 (2 H, d), 8.04 (2 H, d), 7.62 (2 H, d), 7.48 (3 H, m), 5.94 (2 H, s).
Anionic exchange of bromide salt (71a) to hexafluorophosphate salt (71b):
Compound 71a (0.862 g, 2.64 mmol) was dissolved in 10 mL of water. The solution
was stirred as 10 mL of a 0.500 M aqueous NH4PF6 was dipped in over 10 min. The
solution was allowed to stir for an additional 10 min before the precipitated white
hexafluorophosphate salt was filtered, washed with water, and air dried. The yield of
71b was quantitative (1.03 g, 2.64 mmol).
Benzyl-nitrile viologen (BNV) (16): Compound 71b (0.500 g, 1.27 mmol) and
bromoacetonitrile (0.266 mL, 3.82 mmol) were dissolved in 4.00 mL of DCM and
irradiated in a sealed vial using a Biotage Initiator on normal power for 30 min at 100
ᵒC. The off white mixed salt precipitate (0.433 g, 8.45 mmol, 66% reaction yield,
59% overall yeild) was filtered, washed carefully with acetone, and dried by drawing
68

air through the filter cake. The product appeared to be slightly soluble in acetone. 1H
NMR (600 MHz, DMSO) δ 9.55 (4 H, d), 8.85 (4 H, d), 7.65 (2 H, d), 7.49 (3 H, m),
6.12 (2 H, s), 6.00 (2 H, s). 13C NMR (151 MHz, DMSO) δ 150.50, 148.86, 146.45,
145.77, 134.06, 129.54, 129.28, 128.89, 127.31, 127.09, 114.13, 63.55, 47.80. FTMS
+p ESI: m/z, calculated: 286.1339, found: 286.1338 [M–H]+; calculated: 318.1601,
found: 318.1600 [M+MeOH]+.
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Chapter 8: Notes for continued investigations of these probes
The ultimate goal for Hcy detection is to design a chemical probe that can be used
in an at-home testing kit by people with no background in science. To this end the probe
should be inexpensive, non-toxic, stable upon storage at room temperature, amenable to
as few processing steps as possible, react within a reasonable timeframe without the use
of excessive heat, sensitive enough to allow for sample dilution, selective for Hcy in the
presence of other thiols and other interferences, and able to maintain an accurate
quantification of Hcy with variations in matrix compositions.
Currently the known interferences for bridged bis-nitrile viologen probes are
plasma proteins, variations in Cys and GSH concentration, and reducing agents. Larger
plasma proteins cause a curiously intense color change with these probes. Presumably,
the proteins initiate or propagate a radical to the probe. However, high pH and high
concentrations of solvent can produce an equally intense response. To address the
interference by plasma proteins, the mechanism of protein interference should be
identified. Assays done with high concentrations of the plasma protein, albumin, did not
cause significant interference, so a particular protein may be responsible for the probe
response. Identifying the protein could be useful for devising a strategy for removing it
or rendering it inert.
If the dielectric constant of plasma is much lower than the buffer controls, this
may account for the increased reactivity of the probe. Dramatically increasing the ionic
strength of plasma samples could correct this issue or might lead to a method for
removing the proteins via precipitation from ‘salting out. Decreasing the pH would also
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reign in the probe reactivity. Although the few trials that were performed at lower pH in
whole plasma were not successful, the buffer concentration may not have been high
enough to overcome the natural buffering capacity of biological fluids. Some initial
experiments with these probes showed a ‘no response’ selectively for GSH, responding
even less response than blank solutions. This was eventually identified as a pH effect
from exceeding the buffer capacity. Buffers which are compatible with the probe at high
concentrations should be identified and tested with plasma samples at a concentration that
will confidently buffer the solution at the intended pH. Another strategy would be to
dampen the reactivity tuning the redox potential of the probe further by choosing
substituents for the viologen, mindful of the mechanism described here, though any
structure that decreases the reactivity of the probe is accompanied by the risk of
decreased sensitivity as well.
The majority of Hcy is bound to plasma proteins by disulfide linkages. Normally,
free Hcy in plasma is only 1-2% of the total Hcy present.102 To quantify Hcy, the disulfide
bonds must be cleaved with a reducing agent prior to protein removal. If reaction
conditions are found which prevent interference from protein, then the probe must be
compatible with the reducing agent if all the components are to be combined in the directly
in the sample solution. So far the reducing agents TCEP, BME, MPA, dithiothreitol, and
tris(2-carboxyethyl)phosphine reducing agents were found to interfere with the probe
response. It is likely that removal of the reducing agent will be necessary prior to probe
addition. TCEP immobilized on cross-linked beaded agarose (bead size 45 - 165 μm) was
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found to be conveniently removed from plasma samples with mini-prep filter vials (filter
pores 0.20 and 0.45 µm).
These filter vials would simultaneously remove precipitated proteins from plasma
samples. Currently, the sensitivity of the probe does not allow excessive sample dilution
with precipitating agents. Additionally, some precipitating techniques, such as the
addition of excessive organic solvent, affect the probe response. Isoelectric point
precipitation with an acid might work provided the pH could be readjusted for the probe.
Polyethylene glycol (PEG) was found to be compatible with the probe (Figure 43), so
PEG protein precipitation was attempted. However, the proteins were only partially
precipitated at 10% w/v PEG concentration in the sample. Although the protein
interference had diminished substantially after filtering, the remaining interference still
obscured detection of Hcy at biological concentrations.

A

B

Figure 43. Polyethylene glycol (PEG) and dialysis as potential methods to remove
protein interference. Common conditions: 2.00 mM pCN in 80.0 mM phosphate buffer
pH 8.0 after 20 min. (A) 15 µM Hcy where indicated, both vials contain 10% w/v PEG
(B) Dialysate: 15 µM Hcy expected from 30 µM Hcy equilibriated with an equal volume
dialysate across a 3.5 kDa cuttoff membrane for 90 min.
Dialysis membranes may separate immobilized TCEP and precipitated proteins
from samples more effectively than filter vials. Preliminary experiments showed 3.2 kDa
cutoff dialysis membranes were permeable to Hcy (Figure 43) and retained proteins
precipitated by PEG better than micro filtration. There is analyte dilution associated
diffusion across a membrane into the dialysate and the time allowed for equilibration of
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the dialysate is important. Incubation less than 30 min did not allow Hcy to fully
equilibrate and the entire volume of dialysate was osmoticly drawn across the membrane
with times > 4 hr. The appeal of using membrane diffusion for a disposable device to be
used at the point-of-care is the potential to simultaneously remove erythrocytes and
process blood directly from a finger prick. Hcy leaches from erythrocytes over time,
which may be advantageous if the increase in Hcy concentration is predictable and/or
proportional to exogenous Hcy concentrations in the plasma
Once a suitable probe and reaction conditions are identified, probe stability
studies should be performed. The bridged bis-nitrile viologen probes were found to be
hydroscopic, accumulating mass from moisture in the air and degrading over time. Even
when stored under argon in a desiccator at -80 ᵒC, one month of periodic but repeated
opening of stock vials and freeze thaw cycles rendered the bridged bis-nitrile probe
response unreliable. The coumarin analogs did not suffer this issue with stability and
were able to be stored on a dark shelf, at room temperature, for months with no detectable
changes in the 1HNMR spectrum or noticeable differences in reactivity. However, it
should be noted that the mAC coumarin analog did suddenly and completely lose its
ability to fluoresce at certain wavelengths. A static gun was used to calm the
uncooperative material when it was transferred from a stock container. Bombarding the
compound with electrons from the static gun may have caused the abrupt change in
optical properties.
The bridged bis-coumarin viologen probe studies are currently in their infancy.
The Cys selective response observed with oAC was reproducible, consistent, and
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developed quickly in buffer. Perhaps the most informative experiment to be done would
assess potential interferences in biological fluids by reproducing Cys selectivity using
oAC with plasma added to the sample matrix. While the original hypothesis concerning
quenching of the stacked fluorophores remains a valid avenue for investigation, a charge
transfer mechanism of fluorescence appears to be more promising in regards to selective
analyte response. The emission increases that took 12 hr to develop could be indicative
of probe degradation or covalent dimerization of the coumarins. 96 Mild heating should be
examined as a method of speeding up the kinetics of responses that develop slowly.
Although reaction conditions that lead to a selective response for Hcy have not been
exhausted for the coumarin analogs, the next generation of fluorophore bridged viologens
designs should encompass fluorophores likely to participate in charge transfer.
Photosensitization of the viologen probe would not be limited to bridged structures.
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Appendix A: Supporting information

Figure 44. Color development of the pCN probe over 1 hr. 80.0 mM phosphate buffer at
pH 8.0, From left in each panel: blank, 15.0 μM Hcy, 250 μM Cys, 6.00 μM GSH, all
thiols combined.
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Figure 45. Linearity and time point analysis for pCN calibration curve in Figure 15-A.
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Figure 46. Linearity and time point analysis for pCN calibration curve in Figure 15-B.
The time point and λabs of the most linear and sensitive data set for construction of
the calibration curves was determined by plotting the square correlation coefficient (R 2)
(Figure 45-A, Figure 46-B) and the slope (Figure 45-C, Figure 46-C) of regression lines
for the entire range of λabs measured. The local maximum for R2 and slope in the region
of the diagnostic peak was found to be 540 nm. This λabs plotted over time provided the
optimum time point, 30 min (Figure 45-BD, Figure 46-BD). Incidentally, the maximum
of the diagnostic peak is also 540 nm.
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A

B

C

Figure 47. Calibration curve for Hcy using the initial rates of increase. λabs = 540 nm
(A) Each sample contained 25% v/v deproteinized bovine plasma, 2.00 mM pCN probe,
80.0 mM phosphate buffer, 62.5 μM Cys, and 1.50 μM GSH. Slopes of the first 5 min of
each run were used for the y-values. LOD = 2.40 µM and LOQ = 8.00 µM. (B)
Replicates for 3.00 μM Hcy data point. (C) Replicates for 9.00 μM Hcy data point.
A major source of imprecision for the replicates was variability introduced by
plasma deproteinizion. The aliquots of deproteinized plasma did not appear to be
perfectly homogenous, as was evident by the baseline shifting of the spectra from light
scattering off suspended particles (Figure 47-BC). Although baseline shifting was
significant, the initial rates of pCN reacting with Hcy were consistent. Therefore,
measuring the initial rates for quantification eliminates the interference due to scattering.
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This approach also dramatically reduces the time needed to measure each sample. By the
initial rates method, analytical limits were improved from Figure 15-A. The diluted
sample solutions were found to have LOD = 2.40 µM and LOQ = 8.00 µM. These values
correspond to LOD = 9.60 µM and LOQ = 32.0 µM in the plasma after accounting for
the dilution.

A

B

Figure 48. Effect of increasing organic solvent concentration. Data sets corresponding to
each graph were collected using 0.500 mM pCN probe in 80.0 mM phosphate buffer at
pH 8.0 with absorbances at 30 min shown. (A) Increasing the ratio of DMSO in the
reaction medium of non-analyte blanks revealed another peak which would appear
yellow with λabs = 370 nm. (B) λabs at 413 and 540 nm measured for blank solutions and
solutions which contained the combined aminothiols: 15.0 µM Hcy, 250 µM Cys, and
6.00 µM GSH.
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Figure 49. Determination of pCN pKa values by titration with NaOH. Plateaus at pH
6.83 and 7.92 indicated two buffer regions corresponding to pKa1 and pKa2 respectively.

A

B

Figure 50. Determination of BNV pKa by titration with NaOH. (A) Upon the first
aliquot of titrant, the pH spiked and began to drift towards a lower pH, requiring > 1.5
hours to reach equilibrium. Subsequent additions of titrant required moderately less time
to equilibrate. (B) The buffer region indicated a pKa of 8.38.
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Figure 51. Dissolved oxygen increased the initial rate of absorbance at 540 nm.
Reaction conditions: 2.00 mM pCN probe in 80.0 mM phosphate buffer pH 8.0 with 15.0
µM of Hcy in vials labeled ‘Hcy,’ ‘H+Ar,’ and ‘H+O2.’
Figure 51 shows the pCN probe response in relation to dissolved oxygen
concentration. Vials labeled ‘blank’ and ‘Hcy’ were not gassed before the addition of
probe. Argon or oxygen was bubbled through the bulk buffer solutions in the vials
labeled ‘H+Ar’ or ‘H+O2’ respectively for 3 min before the addition of probe. Gassing
with inert argon decreases the relative concentration of dissolved oxygen by
displacement. Likewise, gassing with oxygen enriches the oxygen content of solutions.
At time points 5 and 10 min, λabs = 540 nm was the most intense for the vial
corresponding to the highest oxygen concentration. The ‘H+Ar’ vial, corresponding to
the lowest oxygen content, had an attenuated response at 540 nm compared to the nongassed ‘Hcy’ vial.
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Figure 52. Slopes of λabs = 413 nm used to estimate rates of formation for non-radical
pCN probe product. Measurements performed in 80.0 mM phosphate buffer pH 8.0 with
15% v/v IPA.
Although the evolution of reaction products is a dynamic process with
competitive consecutive and parallel reactions, the essentially 1 st order rate of increase at
λabs = 413 nm with respect to pCN suggests a unimolecular transition state where the
labile hydrogen of the probe dissociates before pCN interacts with Hcy (Table 2).
Table 2. Reaction orders for non-radical pCN probe product with respect to pCN probe
and Hcy analyte. Rates obtained from Figure 52.
pCN probe
Hcy analyte
λabs = 413 nm
order of order of
-1
conc. [M]
conc. [M]
rate [min ]
pCN
Hcy
0.500
0.00
0.00554
1.20
1.00
0.00
0.0127
0.500
0.015
0.00616
0.74
1.00
0.015
0.0103
0.500
0.030
0.00663
0.76
1.00
0.030
0.0112
0.500
0.500
1.00
1.00

0.015
0.030
0.015
0.030

0.00616
0.00663
0.0103
0.0112

0.11
0.12
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Figure 53. Structures of ions 30 – 50 identified in the mass spectra of the pCN and Hcy
reaction mixture.
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Figure 54. Structures of ions 51 – 60 identified in the mass spectra of the pCN and Hcy
reaction mixture.
Table 3. Masses of ions identified in the mass spectra of the pCN and Hcy reaction
mixture. NF = not found. Full specta can be found in Appendix C.
Ion #
Calculated m/z
Found m/z MALDI
Found m/z ESI
105.88, 106.05
105.80, 106.09
NF
30
114.04
NF
14.03
31
138.06
NF
138.08
32
157.06
NF
157.06
33
157.08
NF
157.06
34
158.32
158.34
NF
35
172.06
172.07
NF
36
173.07
172.93, 173.20
NF
37
196.08
NF
196.08
38
196.09
NF
196.08
39
196.09
NF
196.08
40
208.10,
208.60
208.63
208.10,
208.57
41
208.10, 208.60
208.63
208.10, 208.57
42
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43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

blank

Cys

208.41
259.11
259.12
268.09
268.09
314.12
314.12
337.15
389.18
417.15
417.21
495.23
497.24
718.29
793.36
314.12
337.11
337.11

NF
259.14
259.14
268.11
268.11
314.12
314.12
337.17
389.19
417.19
417.19
NF
NF
718.31
793.35
314.12
337.17
337.17

λex

λex

208.57
259.12
259.10
268.09
268.09
314.09
314.09
NF
NF
417.16
417.16
495.13
497.13
NF
NF
314.09
NF
NF

Hcy

λex

GSH

λex

Figure 55. Fluorescence selectivity for Hcy with 50.0 µM mAC in 80.0 mM phosphate
buffer pH 6.0 with 200 µM of the indicated thiol. λex/λem = 485/510 nm. After 12 hr.
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λex

blank

λem [nm]

λex

Cys

λem [nm]

Figure 56. Comparison of oCN blank and 200 µM of Cys in 80.0 mM phosphate buffer
at pH 6.0 after 1 hr. Max λex/λem = 405/500 nm. oCN response was selective for Cys at
pH 8.0 (not shown).

A

B

A

B

Figure 57. Rate of change in viologen λem mirrored λabs in 80.0 mM phosphate buffer at
pH 8.0 without analyte. (A) Fluorescence of 50.0 µM pCN, top: λex = 480 nm with a
scan every hour for 12 hrs, bottom: λex/λem = 480/510 nm. (B) Absorbance of 1.00 mM
pCN with 15% v/v IPA, top: spectrum scanned every 15 min for 12 hrs, bottom: plot of
λabs = 540 nm.
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Appendix C: Mass Spectra
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Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0
collected by positive mode ESI-TOF-MS in MeOH with 0.1% formic acid.
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Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0
collected by positive mode ESI-TOF-MS in MeOH with 0.1% formic acid.
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collected by positive mode ESI-TOF-MS in MeOH with 0.1% formic acid.
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480-580 Da range mass spectrum
Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0
collected by positive mode ESI-TOF-MS in MeOH with 0.1% formic acid.
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Full mass spectrum
Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0 collected by MALDITOF-MS in positive ion mode with α-Cyano-4-hydroxycinnamic acid as the matrix.
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100-350 Da mass spectrum
Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0 collected by MALDITOF-MS in positive ion mode with α-Cyano-4-hydroxycinnamic acid as the matrix.

125

350-600 Da mass spectrum
Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0 collected by MALDITOF-MS in positive ion mode with α-Cyano-4-hydroxycinnamic acid as the matrix.
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600-1000 Da mass spectrum
Reaction between 20.0 mM pCN and 20.0 mM Hcy in 100 mM phosphate buffer pH 8.0 collected by MALDITOF-MS in positive ion mode with α-Cyano-4-hydroxycinnamic acid as the matrix.
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